Continuous Renal Replacement Therapy for a Patient with Severe COVID-19.
Blood Purif
; 50(1): 129-131, 2021.
Artículo
en Inglés
| MEDLINE | ID: covidwho-596558
ABSTRACT
The outbreak of coronavirus disease 2019 (COVID-19) is a global health threat. It is a respiratory disease, and acute kidney injury (AKI) is rare; however, if a patient develops severe AKI, renal replacement therapy (RRT) should be considered. Recently, we had a critically ill COVID-19 patient who developed severe AKI and needed continuous RRT (CRRT). To avoid the potential risk of infection from CRRT effluents, we measured severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic material in the effluents by qRT-PCR, and low copy numbers of the viral genome were detected. Due to unstable hemodynamic status in critically ill patients, CRRT should be the first choice for severe AKI in COVID-19 patients. We suggest prevention of clinical infection and control during administration of RRT in the acute phase of COVID-19 patients with AKI or multiple organ failure.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Lesión Renal Aguda
/
Terapia de Reemplazo Renal Continuo
/
COVID-19
Tipo de estudio:
Reporte de caso
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Blood Purif
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS